Skip to main content

SJR 7 — Delaware

DIRECTING THE STATE EMPLOYEE BENEFITS COMMITTEE AND THE SECRETARY OF HUMAN RESOURCES TO ENGAGE WITH INDEPENDENT CONSULTANTS AND OTHER SUPPLY CHAIN TACTICS FOR COST CONTAINMENT OF PRESCRIPTION DRUGS FOR STATE EMPLOYEES AND RETIREES’ INSURANCE PROGRAMS.

Signed into law 153 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

This is a Substitute for Senate Joint Resolution No. 7. Like Senate Joint Resolution No. 7, this Substitute directs the State Employees Benefits Committee (SEBC) to utilize specific strategies and policies when interacting and contracting with Pharmacy Benefit Managers (PBM) in order to achieve lower cost
pharmaceutical drug benefit plans for the State.

This Substitute differs from Senate Joint Resolution No. 7 by clarifying that the SEBC has a duty to consider all of the following strategies and policies when negotiating for pharmaceuticals:

1. Drug cost transparency.
2. Formation of an independent Pharmacy and Therapeutics Committee.
3. Any other supply chain tactics such as a reverse auction or transparency committee.
4. Compacts with other states to negotiate directly with drug manufacturers.
5. Paying no higher price for all drugs negotiated by Medicare.
6. Requiring PBMs disclose administrative expenses for all pharmaceutical drugs.
7. Requiring PBMs bid based on lowest pricing sources, not average wholesale price.
8. Requiring the SEBC be provided all agreements between PBMs and pharmaceutical companies when those agreements are for drugs contracted for on behalf of the SEBC.
9. Performing audits when the SEBC believes it should be entitled to information to achieve transparency or clarity.

This Substitute differs from Senate Joint Resolution No. 7 by directing the SEBC to prepare a report by August 1, 2026, to summarize any difficulties in implementing any of these policies and to submit the report to the Governor; the President Pro Tempore of the Senate and Speaker of the House of Representatives, for distribution to all members of the General Assembly; the Director and the Librarian of the Division of Legislative Services; and the Public Archives.

Official abstract, as published by the legislature.

  • SJR 7 is a joint resolution in the Delaware Senate, 153 session, introduced May 21, 2025.
  • Sponsored by Ray Seigfried, Bryan Townsend, and Melissa Minor-Brown, with 8 cosponsors.
  • Current status: signed into law.
  • Most recent action (August 25, 2025): Signed by Governor.
  • 3 recorded votes; the most recent, on July 1, 2025, passed 21-0.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Ray Seigfried, Bryan Townsend, Melissa Minor-Brown

Cosponsors (8): Eric Buckson, Stephanie L. Hansen, Marie Pinkney, David P. Sokola, John "Jack" Walsh, David L. Wilson, Jeff Hilovsky, Edward S. Osienski

History

  1. Introduced, completed
  2. Passed Senate, completed
  3. Passed House, completed
  4. Sent to Governor, completed
  5. Signed into law, completed, current stage
  1. Senate was introduced and adopted in lieu of SJR 7 Milestone
  2. Senate Passed By Senate. Votes: 19 YES 2 ABSENT Milestone

    Passage: 19 yes 0 no, 2 other Passed, 100% yes

  3. House Assigned to Administration Committee in House Milestone
  4. Senate Not Worked in Committee
  5. Senate Not Worked in Committee
  6. House Reported Out of Committee (Administration) in House with 5 On Its Merits
  7. House Amendment HA 1 to SS 1 - Passed In House by Voice Vote
  8. House Passed By House. Votes: 39 YES 1 ABSENT 1 VACANT Milestone

    Passage: 39 yes 0 no, 1 other Passed, 100% yes

  9. Senate Suspension of Rules in Senate
  10. Senate Passed By Senate. Votes: 21 YES Milestone

    Passage: 21 yes 0 no Passed, 100% yes

  11. Governor Signed by Governor Milestone Latest

Source: Open States. Last checked November 8, 2026. How we keep this accurate ›